[1] Garcia DM,Marks JE,Latifl HR el al.Childhood eerebellar astrocytomas:is there a role for postoperative irradiation?[J].Int J Radiat Oneol Biol Phys,1990,18(4):815-818.
[2] 陈智,李旭,张宇,等.脑恶性胶质瘤82例放射治疗疗效分析[J].中华放射医学与防护杂志,2006,26(4):410-410.
[3] 梅国顺,杜建新.脑恶性胶质瘤的局部治疗现状[J].中华神经外科疾病研究杂志,2007,4(6):379-381.
[4] Eyüpeoglu IY,Hahnen E,Buslei R,et al.Subereylanilide hydroxamie acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo[J].J Neurochem,2005,93(4):992-999.
[5] Nieholas A,Butowski,Patrieia K,et al.Diagnosis and treatment of recurrent higll-grade astrecytoma[J].J Clin Oncol,2006,24(8): 1273-1280.
[6] Kropacova k Slovinskn L,Misurova E.Cytogenetie changes in the liver of progeny of irradiated male rats[J].J Radia Res,2002,43(2): 125-133.
[7] Khmelevskii EV.Radiotherapy for recurrent breast cancer[J]. Voprosy Onkologii,2000,46(2):167-171.
[8] Pelevina II,Gotlib VIa,Kudriashova OV,et al.Properties of progeny of irradiated cells[J].Tsitologiia,1998,40(5):467-477.
[9] 刘树铮.适应性反应[J].中华放射医学与防护杂志,2000,20(6): 373-377.
[10] 姜桔红,王捷,余忠华,等.照射存活后代的鼻咽癌细胞株放射生物学特性研究[J].实用癌症杂志,2002,26(4):566-568.
[11] Graf R,Hildebrandt B,Tilly W.et al.Dose-escMated conformal radiotherapy of glioblastomas-results of a retrospective comparison applying radiation doses of 60 and 70 Gy[J].Onkologie,2005,28(6-7):325-330.
[12] Ulm AJ 3rd,Friedman WA,Bradshaw P.et al.Radiosurgery in the treatment of malignant gliomas:the University of Florida experience[J].Neurosurgery,2005,57(3):512-517.
[13] Cardinale R,Won M,Choucair A,et al.A phaseⅡ trial of accelerated radiotherapy using weekly stereotaetie conformal boost for supratentorial glioblastoma multiform:RTOG 0023[J].Int J Radiat Oncol Biol Phys,2006,65(5):1422-1428.
[14] Graf R,Hildebrandt B,Tilly W,et al.Dose-escalated confomud radiotherapy of glioblastomas-results of a retrospective comparison applying radiation doses of 60 and 70 Gy[J].Onkologle,2005,28(6-7):325-330.
[15] Stupp R,Mason WP,vtul den Bent MJ,et al.Radiotherapy plus concomitant and adjuvant temomlomide for glioblastonut[J].N Engl J Med,2005,352(10):987-996.
[16] Intergroup radiation therapy oncology group trial 9402.caimeross G,Berkey B,et al.Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglionm:Intergroup Radiation Therapy Oncology Group Trial 9402[J].J Clin Oncol,2006,24(18):2707-2714.
[17] van den Bent MJ,Carpentier AF,Brandes AA,et al.Adjuvant proearbazine,Iomustine,and vincristine improve progression-free survival but not overall survival in newly diagnosed anaplastic oligodendroglionms and oligoastroeytomas:a randomized European Organization for Research and Treatment of Cancer phase III trial[J].J Clin Onenl,2006,24(18):2715-2722.
[18] Anal S,Tanaka M,Shiveriek KT,et al.Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenoearcinoma cells[J].J Urol,2007,177(5):1913-1917.
[19] Nakano Y,Kuroda E,Kito T.et al.Induction of macrophagie prostaglandin E2 synthesis by glioma cells[J].J Neurosurg, 2006.104(4):574-582.
[20] Reardon DA,Quinn JA,Vredenburgh J,el al.Phase Ⅱ trial of irinotecan plus celecoxib in adults with recurrent malignant glioma[J].Cancer,2005,103(2):329-338.